Genomic & Biopharma News

Killifish Embryos Pause Development Without Consequence: Study
Contrary to popular thinking, the period of arrested development is an active state of maintaining muscle integrity.
The Scientist, 2020-02-21 22:43:29

Esperion scores FDA nod for cholesterol-buster Nexletol
Esperion has had a rocky road to approval for its LDL-cholesterol-lowering drug Nexletol after a late-stage trial in 2018 threatened to derail its quest. But after backing its drug up with strong safety data, Esperion has the green light to go to market. 
Fierce Pharma, 2020-02-21 22:15:51

Isotopic Bomb Traces Are a Boon to Biological Dating
The decades-old signature of nuclear testing can reveal the ages of organisms, or even individual cells.
The Scientist, 2020-02-21 22:00:57

Key hires during Q2 2019 at ORB
Deerfield Beach, July 19, 2019 - Ocean Ridge Biosciences (ORB) announces two key hires in Q2 2019.
ORB Company News, 2019-07-20 00:49:36

Newer Vaccine Technologies Deployed to Develop COVID-19 Shot
Researchers look to messenger RNA encased in nanoparticles, DNA plasmids, molecular clamps, and other approaches as they rush to design a vaccine against the new coronavirus.
The Scientist, 2020-02-21 21:05:01

BD, Babson pair up to bring capillary blood draws to retail pharmacies
BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into pharmacies and retail settings.
Fierce Biotech, 2020-02-21 20:21:02

'Boring is good,' Teva CEO Schultz says amid push to hit targets, remove risk
Teva CEO Kåre Schultz has taken the company through a dramatic restructuring aimed at better positioning the company for the future. In an interview with Israel's Calcalist, he shared details of his approach to the turnaround.
Fierce Pharma, 2020-02-21 16:20:50

Puma Biotech’s Nerlynx remains a dud. Will a breast cancer expansion turn things around?
Sales of Puma Biotech’s only commercial product—breast cancer drug Nerlynx—still need improvement, company chief Alan Auerbach acknowledged. But as one analyst sees it, a label expansion may not even be enough to save the struggling med amid increased competition from drugs with impressive data.
Fierce Pharma, 2020-02-21 15:53:21

Consumers more likely to purchase cold and flu products over coronavirus fears, says GlobalData
The start of 2020 has been defined by Coronavirus, which to date has killed over 1,000 people and impacted the lives of thousands more.
News Medical Life Sciences, 2020-02-21 15:46:39

Book Review - Bad Blood - Secrets and Lies in a Silicon Valley Startup
Bad Blood: Secrets and Lies in a Silicon Valley Startup by John Carreyrou chronicles the rise and fall of multibillion-dollar biotech startup Theranos. Theranos was started in 2003 by 19-year-old Elizabeth Holmes, a Stanford dropout and former chemical engineering student. Holmes promised investors that her revolutionary technology would perform hundreds of diagnostic tests from only a couple of drops of blood taken from a nanotainer. The problem was that it never worked. However, by 2013 Theranos had made a hundred-million-dollar deal to put its blood testing technology in Walgreens.
ORB Company Blog, 2019-12-12 22:27:05

Survey: Over half of GPs, nurses who treat type 2 diabetics do not carry out annual kidney test
A new UK-wide survey, conducted by Napp Pharmaceuticals, suggests that over half (54%, n=403) of GPs and nurses who treat patients with type 2 diabetes do not carry out a vital routine test annually, which is used to identify early markers of kidney damage.
News Medical Life Sciences, 2020-02-21 15:46:00